MOTS-c: The Mitochondria-Derived Peptide in Metabolic and Exercise Research

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically the 12S ribosomal RNA gene — making it one of a small class of mitochondria-derived peptides (MDPs). First described by Chang et al. in 2015, MOTS-c has since attracted considerable research interest for its potent effects on metabolic regulation, insulin sensitivity, and exercise capacity in research models. Its discovery challenged the long-held assumption that the mitochondrial genome produces only components of the oxidative phosphorylation machinery, revealing instead an unexpected source of bioactive signalling peptides.

A Peptide From the Mitochondrial Genome

The mitochondrial genome is compact — encoding only 13 proteins, 22 transfer RNAs, and 2 ribosomal RNAs — and was historically considered to serve purely oxidative phosphorylation functions. The identification of MOTS-c within the 12S rRNA sequence revealed a previously unrecognised layer of mitochondrial biology. MOTS-c is produced in multiple tissues, with particularly high expression in skeletal muscle, and its circulating levels change in response to metabolic stress, exercise, and aging — suggesting it functions as an endocrine-like signal linking mitochondrial status to whole-body metabolic regulation.

Mechanisms of Metabolic Action

AMPK Activation

One of the primary mechanisms by which MOTS-c exerts its metabolic effects is through activation of AMP-activated protein kinase (AMPK) — the master metabolic sensor and regulator. AMPK activation by MOTS-c in research models promotes:

• Enhanced glucose uptake: Increased GLUT4 translocation to the plasma membrane in skeletal muscle cells
• Fatty acid oxidation: Stimulation of mitochondrial beta-oxidation pathways
• Inhibition of lipogenesis: Reduced de novo fatty acid and cholesterol synthesis
• Mitochondrial biogenesis: Upregulation of PGC-1alpha and related genes supporting new mitochondrial formation

Folate Cycle and One-Carbon Metabolism

MOTS-c research has identified a novel mechanism involving the folate cycle and one-carbon metabolism. Studies suggest that MOTS-c inhibits the folate cycle enzyme AICAR transformylase, leading to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) — a natural activator of AMPK. This indirect AMPK activation through metabolic intermediates represents a distinctive mechanism not shared by other peptide metabolic regulators.

Insulin Sensitivity Research

MOTS-c administration in research subjects has been consistently associated with improved insulin sensitivity and protection against high-fat diet-induced metabolic dysfunction. In mouse models of diet-induced obesity and insulin resistance, MOTS-c treatment reduces fasting glucose and insulin levels, improves glucose tolerance test outcomes, and attenuates ectopic lipid accumulation in the liver and skeletal muscle. These effects occur at physiologically relevant concentrations and are dependent on AMPK signalling in research models.

Exercise Mimetic Properties

A particularly striking finding in MOTS-c research is its apparent ability to recapitulate aspects of the exercise response at a molecular level. Research has shown that:

• MOTS-c levels rise in circulation following physical exercise in both rodent and human studies
• Exogenous MOTS-c administration improves exercise capacity and endurance in aged mice
• Skeletal muscle MOTS-c expression is regulated by physical activity and declines with sedentary aging
• The metabolic gene expression changes induced by MOTS-c overlap substantially with those induced by exercise training

Aging and Longevity Research

MOTS-c circulating levels decline with age in both rodent and human research subjects, paralleling the age-associated decline in metabolic function and exercise capacity. Studies in aged mice have found that MOTS-c supplementation restores aspects of youthful metabolic phenotype and extends healthy lifespan in some experimental cohorts. This positions MOTS-c as a compound of interest in the intersection of metabolic and longevity research.

Conclusion

MOTS-c represents a fundamentally novel class of bioactive peptide — one encoded within the mitochondrial genome and acting as a systemic signal linking mitochondrial metabolic status to whole-body energy homeostasis. Its potent effects on insulin sensitivity, AMPK activation, fat oxidation, and exercise capacity make it one of the most compelling research compounds in the current landscape of metabolic peptide science. As the study of mitochondria-derived peptides expands, MOTS-c continues to be at the forefront.